Literature DB >> 24987006

Physiological functions of peroxisome proliferator-activated receptor β.

Jaap G Neels1, Paul A Grimaldi1.   

Abstract

The peroxisome proliferator-activated receptors, PPARα, PPARβ, and PPARγ, are a family of transcription factors activated by a diversity of molecules including fatty acids and fatty acid metabolites. PPARs regulate the transcription of a large variety of genes implicated in metabolism, inflammation, proliferation, and differentiation in different cell types. These transcriptional regulations involve both direct transactivation and interaction with other transcriptional regulatory pathways. The functions of PPARα and PPARγ have been extensively documented mainly because these isoforms are activated by molecules clinically used as hypolipidemic and antidiabetic compounds. The physiological functions of PPARβ remained for a while less investigated, but the finding that specific synthetic agonists exert beneficial actions in obese subjects uplifted the studies aimed to elucidate the roles of this PPAR isoform. Intensive work based on pharmacological and genetic approaches and on the use of both in vitro and in vivo models has considerably improved our knowledge on the physiological roles of PPARβ in various cell types. This review will summarize the accumulated evidence for the implication of PPARβ in the regulation of development, metabolism, and inflammation in several tissues, including skeletal muscle, heart, skin, and intestine. Some of these findings indicate that pharmacological activation of PPARβ could be envisioned as a therapeutic option for the correction of metabolic disorders and a variety of inflammatory conditions. However, other experimental data suggesting that activation of PPARβ could result in serious adverse effects, such as carcinogenesis and psoriasis, raise concerns about the clinical use of potent PPARβ agonists.
Copyright © 2014 the American Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24987006     DOI: 10.1152/physrev.00027.2013

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  42 in total

Review 1.  Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization.

Authors:  Jan F C Glatz; Joost J F P Luiken
Journal:  J Lipid Res       Date:  2018-04-07       Impact factor: 5.922

Review 2.  Muscle as a "mediator" of systemic metabolism.

Authors:  Kedryn K Baskin; Benjamin R Winders; Eric N Olson
Journal:  Cell Metab       Date:  2015-02-03       Impact factor: 27.287

3.  PPARD and Interferon Gamma Promote Transformation of Gastric Progenitor Cells and Tumorigenesis in Mice.

Authors:  Xiangsheng Zuo; Yasunori Deguchi; Weiguo Xu; Yi Liu; Haiyan S Li; Daoyan Wei; Rui Tian; Weidong Chen; Min Xu; Yaying Yang; Shen Gao; Jonathan C Jaoude; Fuyao Liu; Sarah P Chrieki; Micheline J Moussalli; Mihai Gagea; Manu M Sebastian; Xiaofeng Zheng; Dongfeng Tan; Russell Broaddus; Jing Wang; Nadim J Ajami; Alton G Swennes; Stephanie S Watowich; Imad Shureiqi
Journal:  Gastroenterology       Date:  2019-03-15       Impact factor: 22.682

4.  Molecular Pathways: Dietary Regulation of Stemness and Tumor Initiation by the PPAR-δ Pathway.

Authors:  Semir Beyaz; Ömer H Yilmaz
Journal:  Clin Cancer Res       Date:  2016-10-04       Impact factor: 12.531

Review 5.  Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation.

Authors:  Amanda Karolina Soares Silva; Christina Alves Peixoto
Journal:  Cell Mol Life Sci       Date:  2018-05-22       Impact factor: 9.261

Review 6.  PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ.

Authors:  Lu Han; Wen-Jun Shen; Stefanie Bittner; Fredric B Kraemer; Salman Azhar
Journal:  Future Cardiol       Date:  2017-06-05

Review 7.  Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.

Authors:  Richard Kones; Umme Rumana
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

8.  Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome.

Authors:  Letizia Giampietro; Antonio Laghezza; Carmen Cerchia; Rosalba Florio; Lucia Recinella; Fabio Capone; Alessandra Ammazzalorso; Isabella Bruno; Barbara De Filippis; Marialuigia Fantacuzzi; Claudio Ferrante; Cristina Maccallini; Paolo Tortorella; Fabio Verginelli; Luigi Brunetti; Alessandro Cama; Rosa Amoroso; Fulvio Loiodice; Antonio Lavecchia
Journal:  ACS Med Chem Lett       Date:  2019-02-25       Impact factor: 4.345

Review 9.  Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer.

Authors:  Jeffrey M Peters; Dae J Kim; Moses T Bility; Michael G Borland; Bokai Zhu; Frank J Gonzalez
Journal:  Mol Carcinog       Date:  2019-05-06       Impact factor: 4.784

10.  Metabolic effects of physiological levels of caffeine in myotubes.

Authors:  Jamie K Schnuck; Lacey M Gould; Hailey A Parry; Michele A Johnson; Nicholas P Gannon; Kyle L Sunderland; Roger A Vaughan
Journal:  J Physiol Biochem       Date:  2017-12-03       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.